Synovial cell protein

Details Synovial cell protein Synovial cell protein

2001-12-21

2009-12-15

Haddad, Maher M (Department: 1644)

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Amino acid sequence disclosed in whole or in part; or...

C514S002600, C530S350000

Reexamination Certificate

active

07632507

ABSTRACT:
The present invention discloses a novel protein called Synoviolin and a gene that encodes it. This protein is expressed specifically by synovial tissue and also accompanies the presence of an auto-antibody that recognizes this protein in rheumatoid arthritis (RA) patients. The protein according to the present invention and its antibody can be expected to be used as specific diagnostic markers for RA. In addition, the gene or protein according to the present invention may be used to permit the screening of drugs to treat RA. Moreover, the present invention provides synoviolin gene transgenic animals. The transgenic animals according to the present invention can be used as RA model animals in the development of pharmaceuticals to treat RA.

REFERENCES:
patent: 2007/0059294 (2007-03-01), Nakajima et al.
patent: 2007/0134720 (2007-06-01), Nakajima et al.
patent: WO-98/45436 (1998-10-01), None
patent: WO 98/45437 (1998-10-01), None
patent: WO-99/64576 (1999-12-01), None
patent: WO-00/55351 (2000-09-01), None
patent: WO 01/34629 (2001-05-01), None
Metzler et al. ‘Solution structure of human CTLA-4 and delineation of a CD80/CD86 binding site conserved in CD28.’ Nature Structural Biol. 4:527-531, 1997.
Bork et al. ‘Powers and Pitfalls in Sequence Analysis: The 70% Hurdle.’ Genome Research. 10:398-400, 2000.
Doerks et al. ‘Protein annotation: detective work for function prediction.’ Trends in Genetics. 14:248-250, 1998.
Smith et al. The challenges of genome sequence annotation or “the devil is in the details”. Nat. Biotech.15:1222-1223, 1997.
Brenner S. ‘Errors in genome annotation.’ Trends in Genetics 15:132-133, 1999.
Bowie et al. Decipering the Message in Protein Sequences: Tolerance to Amino Acid Substitutions. Science 247:1306-1310, 1990.
Lerner et al. Nature. 299:592-596, 1982.
Amano et al., Genes Dev, 17(19):2436-2449 (2003).
Bays et al., Nat Cell Biol, 3(1):24-29 (2001).
EMBL Accession No. AP000449 (Jul. 14, 1999).
EMBL Accession No. AC051660 (Apr. 17, 2000).
European Search Report (Supplementary Partial) mailed on May 6, 2004 for EP application No. 01272293,6 pages.
GENESEQ Accession No. AAE01355 (Jul. 18, 2001).
UNIPROT Accession No. Q20798 (Nov. 1, 1996).
Båvik et al., Proc. Natl. Acad. Sol. USA (1996) 93:3110-3114.
Ho and Mocarski, Virology (1988) 167:279-283.
Steinmayr et al., Proc. Natl. Acad. Sci. USA (1998) 95:3960-3965.
Tsuchimochi, K., “Identification of a Crucial Site for Synoviolin Expression,” Mol. Cell. Biol., vol. 25, No. 16 (2005) p. 7344-7356.
Héon et al., Arch. Ophthalmol. (1996) 114(2):193-198.
Ikegawa et al., Genomics (1996) 35(3):590-592.
Lecka-Czernik et al., Molecular and Cellular Biology (1995) 15(1):120-128.
Nakazawa et al., Rinshou Meneki (2000) 33(2):261-264.
Allen et al., The Journal of Experimental Medicine (1990) 171:231-247.
Davis et al., American Journal of Pathology (2002) 160(1):357-367.
Folliard and Terlain, Agents and Actions (1988) 25(1/2)139-145.

Affiliated with

Also associated with

Rating

Synovial cell protein does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Synovial cell protein, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Synovial cell protein will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4053957